```html

X‑Linked Agranulocytosis

What is X‑linked agranulocytosis?

Agranulocytosis is a serious condition in which the body’s production of neutrophils – a type of white blood cell essential for fighting bacterial infections – falls dramatically, often to fewer than 500 cells per microliter of blood. When the defect is inherited on the X chromosome, the disorder is called X‑linked agranulocytosis. Because the gene responsible resides on the X chromosome, males (who have one X and one Y chromosome) are usually affected, while females are carriers and may have milder or no symptoms.

The condition is most commonly linked to mutations in the ELANE (elastase) or HAX1 genes, which regulate neutrophil maturation and survival. Affected individuals present with recurrent, often severe bacterial infections that begin in early childhood. Without prompt treatment, agranulocytosis can be life‑threatening.

Common Causes

While X‑linked agranulocytosis is primarily genetic, several additional factors can precipitate or worsen neutropenia in people with the underlying mutation. Below are the most frequent contributors:

• ELANE gene mutations – defective neutrophil elastase impairs neutrophil development.
• HAX1 gene mutations – affect mitochondrial integrity and lead to early neutrophil death.
• Drug‑induced neutropenia – certain antibiotics (e.g., clozapine, sulfonamides) can trigger an acute drop in neutrophils in genetically susceptible individuals.
• Autoimmune disorders – conditions such as systemic lupus erythematosus may coexist and further lower neutrophil counts.
• Viral infections – especially varicella‑zoster or hepatitis viruses, which can temporarily suppress bone marrow.
• Radiation or chemotherapy – damage to bone‑marrow stem cells can exacerbate an underlying genetic defect.
• Nutritional deficiencies – severe vitamin B12, folate, or copper deficiency can mimic or aggravate neutropenia.
• Congenital neutrophil storage disease – rare syndromes (e.g., cyclic neutropenia) that share overlapping genetic pathways.
• Environmental toxins – exposure to benzene, pesticides, or heavy metals may suppress marrow function.
• Bone‑marrow failure syndromes – such as Fanconi anemia, which can coexist with X‑linked mutations.

Associated Symptoms

Because neutrophils are the first line of defense against bacteria, a low count leads to characteristic clinical features:

• Fever of unknown origin, often the first sign of infection.
• Painful, erythematous skin lesions (cellulitis) or abscess formation.
• Rapidly spreading oral ulcers, gingivitis, or periodontal disease.
• Recurrent pneumonia, sinusitis, or otitis media.
• Severe sore throat or tonsillitis, sometimes progressing to peritonsillar abscess.
• Gastrointestinal ulcers or colitis presenting with abdominal pain and diarrhea.
• Fungal infections (e.g., candidiasis) that may involve the mouth, esophagus, or skin.
• Prolonged recovery from routine infections and frequent need for antibiotics.

When to See a Doctor

Prompt medical attention can prevent complications. Seek care immediately if you notice any of the following:

• Fever ≥ 38.0 °C (100.4 °F) that persists for more than 24 hours.
• Rapidly enlarging or painful skin lesions, especially with pus.
• Severe sore throat, difficulty swallowing, or drooling.
• Persistent cough, shortness of breath, or chest pain.
• Unexplained abdominal pain, vomiting, or persistent diarrhea.
• Signs of sepsis (confusion, rapid heart rate, low blood pressure, chills).
• Any new symptom after starting a medication known to affect neutrophils.

Diagnosis

Diagnosing X‑linked agranulocytosis involves a combination of laboratory tests, clinical assessment, and genetic studies.

1. Complete Blood Count (CBC) with Differential

A CBC is the first step. In agranulocytosis, the absolute neutrophil count (ANC) falls below 500 cells/µL. The total white‑blood‑cell count may be low, but lymphocytes and monocytes are often normal.

2. Bone Marrow Aspiration/Biopsy

Used to evaluate marrow cellularity and rule out other marrow disorders (e.g., leukemia). In X‑linked forms, the marrow shows a maturation block early in the neutrophil lineage.

3. Genetic Testing

Sequencing of the ELANE, HAX1, and other X‑linked neutrophil‑development genes confirms the diagnosis. Testing is recommended for the patient and, if a carrier, for female relatives.

4. Infectious Work‑up

• Blood cultures (especially if fever is present).
• Chest radiograph or CT for pulmonary infection.
• Swabs of skin lesions, throat, or urine for bacterial/fungal culture.

5. Additional Labs

• Serum vitamin B12, folate, and copper levels to exclude nutritional causes.
• Auto‑immune panel (ANA, anti‑dsDNA) if an autoimmune overlap is suspected.

Treatment Options

Management aims to (1) eradicate active infections, (2) restore neutrophil counts, and (3) prevent future episodes.

Acute Infection Management

• Broad‑spectrum antibiotics (e.g., a third‑generation cephalosporin plus vancomycin) started empirically until cultures identify the pathogen.
• Antifungal agents (e.g., fluconazole) if fungal infection is suspected.
• Hospitalization for severe sepsis, with intravenous fluids and supportive care.

Neutrophil Support

• Granulocyte‑Colony Stimulating Factor (G‑CSF) – filgrastim or pegfilgrastim can raise ANC within 24‑48 hours. Dosing is individualized (usually 5‑10 µg/kg/day until ANC > 1500 cells/µL).
• Stem‑cell transplantation – Considered for patients with refractory disease or severe recurrent infections despite G‑CSF.

Long‑Term Management

• Regular prophylactic antibiotics (e.g., trimethoprim‑sulfamethoxazole) to prevent Pneumocystis jirovecii and other opportunistic infections.
• Vaccinations: annual influenza, pneumococcal conjugate (PCV13) and polysaccharide (PPSV23), Haemophilus influenzae type b, and COVID‑19 vaccines. Live vaccines are generally avoided during periods of severe neutropenia.
• Genetic counseling for families, especially when planning future pregnancies.

Home Care Measures

• Maintain excellent oral hygiene; use chlorhexidine mouthwash to reduce ulcer risk.
• Practice strict hand hygiene and avoid close contact with sick individuals.
• Promptly treat minor cuts or abrasions with antiseptic cleaning and, if indicated, topical antibiotics.
• Track daily temperature and ANC (if you have home lab access) to catch early signs of infection.

Prevention Tips

While the genetic basis cannot be altered, many strategies reduce infection risk:

• Adhere to vaccination schedules – keep immunizations up to date.
• Avoid unnecessary antibiotics that can disrupt normal flora and promote resistance.
• Limit exposure to known neutropenia‑triggering drugs; discuss alternatives with your physician.
• Use protective equipment (e.g., masks in crowded settings during flu season).
• Optimize nutrition – sufficient protein, vitamins B12, folate, and minerals support marrow health.
• Regular monitoring – quarterly CBCs and annual review with a hematologist.
• Family planning counseling – carrier testing for female relatives and possible pre‑implantation genetic diagnosis for couples who wish to avoid transmission.

Emergency Warning Signs

References

• Mayo Clinic. “Agranulocytosis.” https://www.mayoclinic.org
• National Institutes of Health, National Heart, Lung, and Blood Institute. “Severe Congenital Neutropenia.” https://www.nhlbi.nih.gov
• World Health Organization. “Guidelines for the Management of Sepsis and Septic Shock.” 2021.
• Cleveland Clinic. “G‑CSF (Filgrastim) & Pegfilgrastim.” https://my.clevelandclinic.org
• American Society of Hematology. “Congenital Neutropenia.” 2022. https://www.hematology.org

```